The present invention relates to transgenic animals expressing a
hypersensitive nicotinic acetylcholine receptor. Transgenic animals have
point mutations in the nucleic acid sequence encoding the .alpha.4 subunit
of the receptor that result in increased sensitivity to nicotine. Such
transgenic animals are model systems for nicotine addiction and certain
types of epilepsy.
